4 ms·
We finally found the first morbidity signal of GLP-1s (or lack thereof). These are life changing drugs, but like plastic we'll see their effects in force withi
by jryio 7mo ago
We finally found the first morbidity signal of GLP-1s (or lack thereof).
These are life changing drugs, but like plastic we'll see their effects in force within this generation:
> The longer time spent off GLP-1s, the greater the risk of major cardiovascular events—up to 22 percent for those who abstained for two years.
- stavros 7mo agoDoesn't it make sense that, if you were taking a drug that reduces morbidity, you'll get increased morbidity if you stop it?
- jryio 7mo agoNot if having a heart attack within 1 year at a higher rate is an co-morbidity factor when the primary treatment was for obesity or diabetes (not stating that obesity and heart disease are not positively correlated). To use a dense analogy: if I stopped brushing my teeth I would not expect to die of gum disease.
- malfist 7mo agoI don't think you read the study. The people returned to their pre treatment risk profile after ceasing treatment
- cthalupa 7mo agoYou are misunderstanding the study (largely because the article heavily misrepresents it, would be my guess) They do not see an increase against their pre-GLP1 baseline risk - they see a reversal of the cardioprotective benefits the drug provided while they were on it.
- TaupeRanger 7mo agoYou failed to understand the results of the study and quoted a passage that does not in any way support your assertion.